Hongxin Biology

Hongxin Bio is an mRNA drug developer, focusing on nucleic acid drug delivery and RNA drug development.

Number of Funding Rounds

Total Funding Amount

1

—

Hongxin Biology has raised a total of — in funding over 2 rounds. Their latest funding was raised on Dec 30, 2022 from a Angel round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Dec 30, 2022	Angel	—	2	Hongtao Capital	—	Detail

Number of Lead Investors

Number of Investors

1

2

Hongxin Biology is funded by 2 investors. Hongtao Capital and Nanling Fund are the most recent investors.

Investor Name	Lead Investor	Funding Round
Hongtao Capital	Yes	Angel
Nanling Fund	—	Angel